Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors

Previously, we discovered linomide analogues as novel HIV-1 integrase (IN) inhibitors. Here, to make possible
structure–activity relationships, we report on the design and synthesis of a series of substituted
dihydroquinoline-3-carboxylic acids. The crystal structure of the representative compound 2c has also
been solved. Among the eight new analogues, 2e showed a potency in inhibiting IN strand transfer catalytic
activity similar to the reference diketo acid inhibitor L-731,988 (IC50 = 0.9 lM vs. 0.54 lM, for 2e
and L-731,988, respectively). Furthermore, none of the compounds showed significant cytotoxicity in
two tested cancer cell lines. These compounds represent an interesting prototype of IN inhibitors, potentially
involved in a metal chelating mechanism, and further optimization is warranted.